STEPHEN C. FARRELL - 28 Mar 2022 Form 4 Insider Report for Convey Health Solutions Holdings, Inc.

Role: CHIEF EXECUTIVE OFFICER, Director
Signature: /s/ Giovanni Castellanos, attorney-in-fact for Stephen C. Farrell
Issuer symbol: N/A
Transactions as of: 28 Mar 2022
Net transactions value: $0
Form type: 4
Filing time: 30 Mar 2022, 16:41:31 UTC
Previous filing: 25 Jun 2021
Next filing: 17 Jun 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CNVY	Restricted Stock Units	Award	$0	+355,561		$0.000000	355,561	28 Mar 2022	Common Stock, par value $0.01 per share	355,561		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents 355,561 restricted stock units. Restricted stock units are subject to a four year time-based vesting schedule with 25% vesting on March 28, 2023, and the remainder vesting in 12 equal installments every three months thereafter, subject to Mr. Farrell's continued service with Convey Health Solutions Holdings, Inc. (the "Issuer") through the applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units will be settled in common stock.

Content

Represents 355,561 restricted stock units. Restricted stock units are subject to a four year time-based vesting schedule with 25% vesting on March 28, 2023, and the remainder vesting in 12 equal installments every three months thereafter, subject to Mr. Farrell's continued service with Convey Health Solutions Holdings, Inc. (the "Issuer") through the applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units will be settled in common stock.